Navigation Links
New discovery paves the way for new diagnosis of serious lung disease
Date:3/2/2009

The discovery by Uppsala University researchers of a previously unknown protein in the cells of the lower air ways brings new potential for early diagnosis of a serious lung disease. The findings, published today in the Web edition of the American journal Proceedings of the National Academy of Sciences, can also provide new knowledge of the cause of common diseases like asthma and chronic bronchitis.

Researchers at Uppsala University and Uppsala University Hospital have identified a protein in the lungs that is important to the immune defense system in an autoimmune lung disorder that is not seldom fatal. The newly discovered protein, called KCNRG, occurs in cells in the lower air ways found on the surface of the bronchia. This observation enables researchers to study more closely the first phase of the autoimmune disease, that is, when the immune system erroneously attacks the body's own tissues instead of attacking foreign organisms like bacteria or viruses. The discovery also provides new avenues for developing new diagnostic methods.

The researchers used an unusual hereditary autoimmune disorder, autoimmune polyendocrine syndrome type 1 (APS-1), as a model. Patients with this disease are afflicted by the immune system erroneously attacking several tissues, such as the liver, insulin-producing cells, and adrenal glands.

"Only now have we understood that the lungs are attacked as well and that in many cases this is the most serious component of the disease APS-1," says Dr. Mohammad Alimohammadi.

"It's our hope that the discovery of the protein that the immune system targets, besides making early diagnosis possible, will also be possible to use in understanding the mechanism behind the occurrence of common public health disorders like asthma and chronic bronchitis."


'/>"/>

Contact: Mohammad Alimohammadi
mohammad.alimohammadi@medsci.uu.se
46-070-882-9922
Uppsala University
Source:Eurekalert

Page: 1

Related biology news :

1. La Jolla Institute signs exclusive license agreement with Medimmune on major asthma discovery
2. Rett Syndrome Research Trust advisor makes significant discovery
3. Singapore research organisations team up to advance drug discovery using brain tumor stem cells
4. Breaking the barrier: Discovery of anti-resistance factors and novel ocean drugs
5. Major step for drug discovery and diagnostics
6. Cell-building discovery could reduce need for some animal research
7. New discovery may lead to new class of allergy drugs
8. Discovery could lead to a new animal model for hepatitis C
9. Billion-year revision of plant evolution timeline may stem from discovery of lignin in seaweed
10. Cancer-causing gene discovery suggests new therapies
11. Jumbo-sized discovery made in Malaysia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... the health IT company that operates the largest health ... today announced a Series B investment from BlueCross BlueShield ... investment and acquisition accelerates higi,s strategy to create the ... activities through the collection and workflow integration of ambient ... secures data today on behalf of over 36 million ...
(Date:3/24/2017)... 2017 The Controller General of Immigration from Maldives ... Algeen have received the prestigious international IAIR Award for the most ... Reading ... Maldives ... Abdulla Algeen (small picture on the right) have received the IAIR award ...
(Date:3/23/2017)... DUBLIN , Mar. 23, 2017 Research ... Anti-Theft System Market Analysis & Trends - Industry Forecast to 2025" ... ... to grow at a CAGR of around 8.8% over the next ... This industry report analyzes the market estimates and forecasts for all ...
Breaking Biology News(10 mins):
(Date:10/9/2017)... Oct. 9, 2017  BioTech Holdings announced today ... which its ProCell stem cell therapy prevents limb ... The Company, demonstrated that treatment with ProCell resulted ... saved as compared to standard bone marrow stem ... resulted in reduction of therapeutic effect.  ...
(Date:10/9/2017)... , ... October 09, 2017 , ... ... four-tiered line of medical marijuana products targeting the needs of consumers who are ... of Kindred takes place in Phoenix, Arizona. , As operators of two successful ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... technologies, launched its ProxiMeta™ Hi-C metagenome deconvolution product, featuring the first commercially ... cloud-based bioinformatics software to perform Hi-C metagenome deconvolution using their own facilities, ...
(Date:10/6/2017)... ... 06, 2017 , ... On Tuesday, October 24th, ABC² (Accelerate ... first-ever adaptive clinical trial for glioblastoma (GBM). The featured speaker will be Dr. ... open to the public, but registration is required. , WHAT: ABC² Brain ...
Breaking Biology Technology: